Hautärzte Zentrum Hannover

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Hidradenitis suppurativa2 trials
• Atopic dermatitis (eczema)1 trial

Phase

• Phase 33 trials

Status

• Active, not recruiting2 trials
• Completed1 trial

Lead sponsor

• Incyte Corporation2 trials
• LEO Pharma1 trial

Running trials

• Active, not recruiting

  Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Hidradenitis Suppurativa (TRuE-HS2)

  NCT06958211· Phase 3· Incyte Corporation· Source

• Active, not recruiting

  A Study to Evaluate the Long-Term Safety and Efficacy of Povorcitinib in Participants With Moderate to Severe Hidradenitis Suppurativa

  NCT06212999· Phase 3· Incyte Corporation· Source

Closed trials

• Completed

  A 32-week Trial to Evaluate the Efficacy and Safety of Tralokinumab in Subjects With Moderate-to-severe Atopic Hand Eczema Who Are Candidates for Systemic Therapy

  NCT05958407· Phase 3· LEO Pharma· Source